- Blood Sample
- Tissue Sample
- Others
Lipidomics Market size is anticipated to be valued at USD 50.0 million in 2021 and is expanded to grow at a significant CAGR of 8.0% over 2022-2028. Lipidomics is a growing field of biomedical study that encompasses lipidome analysis. It's a complete and quantitative description of a collection of lipid species found in an organism. The worldwide lipidomics market is predicted to benefit from a wide range of lipidomics applications, as well as an increase in the prevalence of target diseases such as malignancies and the breadth of clinical trials and toxicological investigations. During the forecast period, the Lipidomics market is expected to rise rapidly. Novel technology approvals, as well as other organic growth tactics such as patents and events, are being prioritized by a lot of companies. Acquisitions, as well as collaborations and partnerships, were considered inorganic growth tactics in the market. These activities have paved the way for the expansion of business and the customer base of market players. The rise in need for precise illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Growth is attributed to meeting the requirements of aging populations and infants, and the prevalence of chronic diseases and changing food habits contribute to the intake of supplements and energy-providing food are boosting the global lipidomics market. In the forecast period of 2021-2028, rising raw material and technology costs are expected to pose a challenge to the lipid market. Over the anticipated period, the market is expected to rise due to an increase in the demand for precise illness diagnosis, growth in demand for personalized treatment, technological advancements in the field of lipidomics, and large investments from the public and commercial sectors in R&D activities.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rise in the need for accurate illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Increasing industrialization and growing health consciousness and awareness about the health benefits of lipids. However, the lipidomics market's growth is hampered by strict regulatory rules, a lack of modern instruments, a lack of technology acceptance, and a scarcity of experienced researchers
The lipidomics market is projected to expand at a CAGR of 8.0% during the forecast period
Lipotype GmbH, Metabolon, Inc., Waters Corporation, Creative Proteomics, Thermo Fisher Scientific, MetaSysX
North America is the fastest-growing region for lipidomics market